Zytiga-FR (Abiraterone Tablet) 250mg

Abiraterone 250mg tablets are prescribed for prostate cancer management. This oral medication helps reduce androgen production in the body. Store at room temperature and keep away from moisture. Always follow healthcare provider instructions.

Strength

250mg

Pack Size

120s

Storage

Ambient

Manufacturer / TM Owner

Janssen Cilag Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Abiraterone 250mg tablets are used to treat prostate cancer by lowering hormone levels that fuel cancer growth. It is often prescribed alongside other therapies for advanced cases. This medication helps manage symptoms and slow disease progression. Patients may wonder what abiraterone 250mg is used for in cancer treatment.

Side Effects

Abiraterone 250mg tablets may cause side effects like fatigue, joint pain, or hot flashes. Some users report digestive discomfort or swelling in the legs. These effects vary by individual and should be monitored. Always report persistent symptoms to a healthcare provider.

Precautions & Warnings

Store abiraterone 250mg tablets at room temperature away from moisture and direct light. Keep out of reach of children and pets. Inform your doctor about all medications and health conditions before use. Avoid grapefruit products while taking this medication.

Avoid Interactions

Abiraterone 250mg may interact with certain medications, including CYP3A4 inhibitors or inducers. Avoid alcohol and grapefruit products as they can affect how the drug works. Discuss all current prescriptions with your healthcare provider. Some herbal supplements may also interfere with abiraterone.

Frequently Asked Questions

Abiraterone 250mg is used to treat prostate cancer by reducing androgen levels in the body.

Store at room temperature away from moisture and direct light. Keep the container tightly closed.

Consult your healthcare provider before combining abiraterone with other drugs or supplements.

Common side effects include fatigue, joint pain, hot flashes, and digestive discomfort.

This medication is not intended for use by pregnant individuals or those planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.